Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis
Introduction An important consideration in the treatment of patients with psoriatic arthritis (PsA) is whether the addition of methotrexate (MTX) to biologics has greater efficacy than biologic monotherapy with respect to efficacy outcomes in these patients.Objectives To conduct a network meta-analy...
Saved in:
| Main Authors: | Philip J Mease, Daniel E Furst, Jeffrey R Lisse, Christophe Sapin, Kirstin Griffing, Sarah Ross, Paulo Reis, Aisha Vadhariya, Soumya Reddy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-02-01
|
| Series: | RMD Open |
| Online Access: | https://rmdopen.bmj.com/content/10/1/e003423.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis
by: N. V. Chichasova, et al.
Published: (2021-06-01) -
Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2016-09-01) -
Use of methotrexate in the treatment of psoriasis and psoriatic arthritis
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-06-01) -
Role of methotrexate in biologics use with psoriasis and psoriatic arthritis
by: Ting-Ting Cheng, et al.
Published: (2025-04-01) -
What Matters in Psoriatic Arthritis: A Comparison of Patient and Clinician Perspectives
by: Philip J. Mease, et al.
Published: (2025-01-01)